Real‐world experience of adalimumab therapy for patients with ulcerative colitis: A single tertiary medical center experience in Central Taiwan
Open Access
- 15 October 2021
- journal article
- research article
- Published by Wiley in Advances in Digestive Medicine
- Vol. 10 (1), 28-33
- https://doi.org/10.1002/aid2.13300
Abstract
No abstract availableKeywords
Funding Information
- Changhua Christian Hospital (109‐CCH‐IRP‐008, 110‐CCH‐IRP‐020)
This publication has 28 references indexed in Scilit:
- Balloon-Assisted Enteroscopy and Capsule Endoscopy in Suspected Small Bowel Crohn’s DiseaseClinical Endoscopy, 2017
- Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel DiseaseIntestinal Research, 2017
- Long-term assessment of clinical response to adalimumab therapy in refractory ulcerative colitisEuropean Journal of Gastroenterology & Hepatology, 2016
- Efficacy and Safety of Adalimumab in Ulcerative Colitis Refractory to Conventional Therapy in Routine Clinical PracticeJournal of Crohn's and Colitis, 2015
- Occurrence of Sweet syndrome under anti-TNFClinical Rheumatology, 2015
- Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3The American Journal of Gastroenterology, 2014
- Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn's Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) StudyIntestinal Research, 2014
- Adalimumab in active ulcerative colitis: A “real-life” observational studyDigestive and Liver Disease, 2013
- Long-term follow-up of ulcerative colitis in TaiwanJournal of the Chinese Medical Association, 2012
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative ColitisGastroenterology, 2012